Multi 50+ Women
Originaltext auf Französisch.
In Kanada zugelassenes natürliches Gesundheitsprodukt
Falls dieses Produkt in Frankreich verkauft würde
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. Französische Verordnungen vom 9. Mai 2006 (Nährstoffe), 24. Juni 2014 (Pflanzen) und 26. September 2016 (andere Stoffe), konsolidierte LEGI-Sammlung, abgerufen am 23. Oktober 2026.
Eine Tagesmenge wird nur bei ausdrücklicher oraler Dosierung für Erwachsene berechnet, die pro Tag und in einer zur Produktform passenden festen Einheit angegeben ist. Mehrdeutige Einheiten, Flüssigkeiten, Pulver und pädiatrische Dosen werden nicht hochgerechnet. Eine nicht berechnete Menge wird nicht mit Dosisgrenzwerten verglichen. Diese Analyse stellt weder eine Verkaufszulassung in Frankreich noch eine Sicherheits- oder Wirksamkeitsbewertung dar.
Zusammensetzung
| Arzneilicher Inhaltsstoff und Quelle | Je Dosiseinheit laut Quelle | Täglich höchstens, Erwachsene |
|---|---|---|
| Lepidium meyenii Quelle : Lepidium meyenii - racine Extrakt : Matériel brut sec Extraktionsverhältnis : 10:1 Trockenpflanzenäquivalent : 80 mg | 8 mg | Nicht berechnet |
| Vanadium Quelle : Citrate de vanadium | 8 microgram | Nicht berechnet |
| Inositol Quelle : Inositol | 8 mg | Nicht berechnet |
| Curcuma longa Quelle : Curcuma longa - rhizome Extrakt : Matériel brut sec Extraktionsverhältnis : 20:1 Trockenpflanzenäquivalent : 340 mg | 17 mg | Nicht berechnet |
| 1-Carboxy-N,N,N-sel interne de triméthylméthanaminium Quelle : Chlorhydrate de bétaine | 7 mg | Nicht berechnet |
| Bêta-carotène Quelle : bêta-carotène | 560 microgram | Nicht berechnet |
| Bêta-carotène Quelle : bêta-carotène | 933 UI | Nicht berechnet |
| Iode Quelle : Iodure de potassium | 50 microgram | Nicht berechnet |
| Vitamine B6 Quelle : Chlorhydrate de pyridoxine | 8 mg | Nicht berechnet |
| Vitamine B6 Quelle : Pyridoxal 5'-phosphate | 8 mg | Nicht berechnet |
| Cuivre Quelle : Citrate de cuivre (II) | 333 microgram | Nicht berechnet |
Nicht arzneiliche Inhaltsstoffe
Cellulose microcristalline, Stéarate de magnésium, Dioxyde de silicium, Hypromellose
In Kanada empfohlene Dosen
| Bevölkerungsgruppe | Alter | Menge pro Einnahme | Häufigkeit |
|---|---|---|---|
| Femmes | minimum : 50 ans | 1 Capsule | 3 jours |
In Kanada zugelassene Verwendungen
Helps normal growth. Helps support bone health. Helps to build strong bones and teeth. Helps to form red blood cells. Helps to maintain (proper) muscle function. Helps to maintain eyesight and in the development and maintenance of night vision. Helps to maintain eyesight/skin/membranes/(and) immune function (health). Helps to maintain healthy bones, hair, nail and/or skin. Helps to maintain healthy hair, nail, mucous membranes and/or skin. Helps to maintain healthy metabolism. Helps to maintain healthy mucous membranes. Helps to maintain healthy skin and/or mucous membranes. Helps to maintain healthy skin. Helps to maintain heart muscle function. Helps to maintain normal blood glucose levels. Helps to maintain normal electrolyte balance. Helps to maintain normal function of the thyroid gland. Helps to maintain normal iron transport in the body. Helps to maintain normal metabolism of iron. Helps to maintain normal muscle function. Helps to maintain normal red blood cells. Helps to maintain proper muscle function, including the heart muscle. Helps to maintain the body's ability to metabolize nutrients and helps in tissue formation. Helps to maintain the body's ability to metabolize nutrients. Helps to produce and repair connective tissue. Helps to provide eyesight/skin/membranes/(and) immune function support. Helps to support the immune system. Helps with immune function. Maintains good health. Maintains healthy hair, skin and nails. Maintains healthy skin. Mineral supplement. Multi-mineral supplement. Multi-vitamin and multi-mineral supplement. Multi-vitamin supplement. Provides support for healthy glucose metabolism. Provides/Source of/An electrolyte (for the maintenance of good health). Provitamin A/Source of Vitamin A for the maintenance of good health. Provitamin A/Source of Vitamin A to help/helps in the development and maintenance of night vision, bones and teeth. Provitamin A/Source of Vitamin A to help/helps in the development and maintenance of night vision. Provitamin A/Source of Vitamin A to help/helps maintain eyesight, skin, membranes and immune function and helps in the development and maintenance of night vision, bones and teeth. Provitamin A/Source of Vitamin A to help/helps maintain eyesight, skin, membranes and immune function. Source of Vitamin A. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant for the maintenance of good health/eye health. Source of/An antioxidant that helps (to): a) fight/b) protect (cells) against/c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/An antioxidant that helps protect against oxidative stress. Source of/An antioxidant that protects the fat in body tissues from oxidation. Source of/An electrolyte (for the maintenance of good health). Supports energy production. Supports good health. Vitamin and mineral supplement. Vitamin supplement. (Provides) An antioxidant. Helps to maintain and/or support cardiovascular health.
Originaltext auf Englisch.
Used in Herbal Medicine (as a hormone normaliser) to help stabilise menstrual cycle irregularities and relieve premenstrual symptoms. Used in Herbal Medicine (as a hormone normaliser) to help stabilise menstrual cycle irregularities. Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine to help relieve symptoms associated with menopause, such as hot flushes. Curcuma longa is traditionally used in Herbal Medicine as an anti-inflammatory to help relieve joint pain. Curcuma longa is traditionally used in Herbal Medicine to help relieve flatulent dyspepsia (carminative). Source of/Provides antioxidants. Used in Herbal Medicine as a hepatoprotectant/liver protectant. Used in Herbal Medicine to aid digestion. Used in Herbal Medicine to increase bile excretion by the liver (choleretic) and stimulate contraction of the gallbladder (cholagogue). Actaea racemosa is traditionally used in Herbal Medicine to help ease nervous tension (calmative). Actaea racemosa is traditionally used in Herbal Medicine to help relieve muscle and joint pain associated with rheumatic conditions (such as rheumatoid arthritis, osteoarthritis and/or fibrositis), and pain associated with neuralgia (such as sciatica). Actaea racemosa is traditionally used in Herbal Medicine to help relieve the pain associated with menstruation. (Used in Herbal Medicine to) help(s) relieve symptoms associated with menopause. Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine to help relieve the pain associated with menstruation as well as premenstrual symptoms. Source of/Provides antioxidants. (Helps) support eye/skin health. A factor in the maintenance of good health and normal growth and development. A factor in the maintenance of good health. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Antioxidant for good health. As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Calcium intake, when combined with sufficient Vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Contributes to maintaining general health. For maintaining general health. Healthy skin and/or mucous membranes support. Helps (to) maintain/support immune function. Helps (to) maintain/support immune function/system. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps in connective tissue formation. Helps in energy metabolism and in tissue formation. Helps in energy metabolism in the body. Helps in energy metabolism, tissue formation and bone development. Helps in energy production. Helps in the absorption (and use) of calcium and phosphorus. Helps in the development and maintenance of bones and teeth and maintain proper muscle function and tissue formation. Helps in the development and maintenance of bones and teeth. Helps in the development and maintenance of bones, cartilage, teeth and/or gums and in connective tissue formation. Helps in the development and maintenance of bones, cartilage, teeth and/or gums. Helps in the development and maintenance of bones. Helps in the development and maintenance of night vision. Helps in the function of the thyroid gland. Helps in the maintenance of bones. Helps in the normal function of the immune system. Helps in tissue formation. Helps in wound healing and connective tissue formation. Helps in wound healing. Helps maintain healthy skin and connective tissue formation. Helps maintain proper muscle function and tissue formation. Helps normal growth and development.
Originaltext auf Englisch.
Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.
Warnhinweise in Kanada
Cautions and Warnings : Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are breastfeeding, have a liver disorder or develop symptoms of liver trouble. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are breastfeeding, have gallstones, a bile duct obstruction, stomach ulcers. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking blood pressure medication. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking blood thinners. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have a history of non-melanoma skin cancer. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have a peptic ulcer or excess stomach acid.
Originaltext auf Englisch.
Produktdaten
- Andere Namen
- 100% Complete Multivitamin Women 50+, Complete Multi 50+ Women, Multiple Vitamins and Minerals Womens 50+
- Inhaber
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN oder DIN-HM
- 80119132
- Status
- Aktive Lizenz
- Lizenzdatum
- 3. Juni 2022
- Überarbeitungsdatum
- 8. September 2026
- Form
- Capsule, dur
- Verabreichungsweg
- Orale
- Art des Antrags
- Générale (non traditionelle)
Quelle
Amtlicher Health-Canada-Eintrag, Zulassung 80119132
Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Originaltext auf Englisch.
Originaltext auf Französisch.
Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.
Offizielle Warnhinweise (Health Canada)
Health Canada veröffentlicht Warnhinweise zu diesen Zutaten:
- Lepidium meyenii
Warnhinweis, Geltungsbedingung und zitierte Studien lesen
Offizieller Originaltext auf Englisch.
Maca - Lepidium Meyenii
Art der Anwendung: Oral
Vorsichtsmaßnahmen und Warnhinweise
Anwendungsbedingung: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Gilt für Produkte: providing 0.6 g or more dried root/hypocotyl, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).
Von Health Canada zitierte Quellen (1)
- Valentova K, Stejskal D, Bartek J, Dvoráckova S, Kren V, Ulrichova J, Simanek V. Maca (Lepidium meyenii) and yacon (Smallanthus sonchifolius) in combination with silymarin as food supplements: in vivo safety assessment. Food and Chemical Toxicology 2008;46(3):1006-1013. PubMed Randomisierte Studie
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
Von Health Canada zitierte Quellen (2)
- Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomisierte Studie
- Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed
Anwendungsbedingung: Healthy mood balance; Sexual health.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
Von Health Canada zitierte Quellen (3)
- Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Archives of Sexual Behavior 2010;39(2):221-239. PubMed Übersichtsartikel
- Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomisierte Studie
- Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed
- Curcuma longa
Warnhinweis, Geltungsbedingung und zitierte Studien lesen
Offizieller Originaltext auf Englisch.
TURMERIC - CURCUMA LONGA - Oral
Art der Anwendung: Oral (ESCOP 2003; Blumenthal et al. 2000)
Vorsichtsmaßnahmen und Warnhinweise
Anwendungsbedingung: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).
Von Health Canada zitierte Quellen (2)
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
1 im Text zitierte Studie hat keine passende Angabe im Literaturverzeichnis der Monografie (siehe Auffälligkeiten auf der Quellenseite).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).
Von Health Canada zitierte Quellen (6)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).
Von Health Canada zitierte Quellen (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).
Von Health Canada zitierte Quellen (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Anwendungsbedingung: All uses except for Source of antioxidants and Hepatoprotectant.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Monografie von Health Canada vom 26. September 2025
Turmeric -CURCUMA LONGA - Topical
Vorsichtsmaßnahmen und Warnhinweise
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Gegenanzeigen
Do not use on deep or puncture wounds, animal bites or serious burns.
Sie betreffen die Zutat, nicht dieses Produkt oder seine Dosis. Sie ersetzen keinen ärztlichen Rat.
Liste in der amtlichen Überarbeitung vom (Register: Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise).
Das Produkt hat sich geändert? Fotografieren Sie die Verpackung.
Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.